Geoff Oxnard MD

@geoff_oxnard

Drug & diagnostic developer | Thoracic oncology, Boston Medical Center | Husband, father of 4, splitter of wood | Opinions my own

Boston, MA coi.asco.org/share/HHV-CHBV… Joined September 2016

151 Following 4.1K Followers 1.9K Posts

Latest posts 5

Pinned post

Geoff Oxnard MD @geoff_oxnard Oct 27, 2025

Fantastic energy this week presenting preliminary findings from our SOLARA trial of BH-30643 in Boston. Please check out the poster which is now on the BHT pipeline website! Study enrolling full steam ahead with a focus on on-target resistance and TKI-naive #EGFR-mutant NSCLC.

Geoff Oxnard MD @geoff_oxnard Aug 27, 2025

Bonnie Addario was an incredible champion for individualized lung cancer care. Her belief in me made a formative impact on my development as a lung cancer researcher. And the sea change she catalyzed - we will all persevere in pushing it forward! Memory eternal, Bonnie

GO2 for Lung Cancer @GO2forLungCancr Aug 26, 2025

We mourn the loss of our co-founder, Bonnie J. Addario, an extraordinary leader whose vision, strength, and generosity forever changed the course of lung cancer. Her legacy lives on in all whose lives she touched.

View quoted post on X

Geoff Oxnard MD @geoff_oxnard Apr 29, 2025

Excited to present our poster today at #AACR25 on the design and discovery of our new OMNI-EGFR inhibitor, BH-30643. To learn more, please stop by the poster this afternoon (S20, B18) or download the poster from our pipeline website at bhtherapeutics.com.

Geoff Oxnard MD @geoff_oxnard Feb 20, 2025

Masterful summary of the EGFR landscape, across diverse mutation subtypes, by @LeXiuning at #TTLC25

Geoff Oxnard MD @geoff_oxnard Jan 12, 2025

Excited to announce I'm joining BlossomHill Therapeutics as CMO! I’ve always believed in patient-centered cancer therapies. None better to team with than our CEO Jean Cui who designed some of the most effective & creative macrocyclic TKIs on the market:

businesswire.com/news/home/2025…

www.businesswire.com BlossomHill Therapeutics Appoints Geoff Oxnard, M.D., as Chief Medical Officer and Executive Vice... BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer ...